Circulating miR-221 Expression Level and Prognosis of Cutaneous Malignant Melanoma

BACKGROUND: The aim of this study was to investigate the feasibility of using serum miR-221 as a noninvasive prognostic biomarker for cutaneous malignant melanoma (CMM). MATERIAL/METHODS: We measured the expression levels of miR-221 in serum samples from 72 CMM patients and 54 healthy controls by re...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ping, He, Quan-yong, Luo, Chen-qun, Qian, Li-yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259523/
https://www.ncbi.nlm.nih.gov/pubmed/25430553
http://dx.doi.org/10.12659/MSM.891327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259523/
https://www.ncbi.nlm.nih.gov/pubmed/25430553
http://dx.doi.org/10.12659/MSM.891327

Ejemplares similares